C. Sato

发表

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

N Enomoto, N. Enomoto, M. Kurosaki, 1996, The New England journal of medicine.

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

N. Enomoto, M. Kurosaki, N. Izumi, 1995, The Journal of clinical investigation.

Effects of caffeine on paracetamol activation in rat and mouse liver microsomes.

F. Marumo, C. Sato, J. Liu, 1992, Xenobiotica; the fate of foreign compounds in biological systems.

Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis

N. Enomoto, M. Kurosaki, N. Izumi, 1996, Journal of medical virology.

Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy

N. Enomoto, M. Kurosaki, N. Sakamoto, 2005, Journal of viral hepatitis.

Selection of hepatitis C virus quasispecies during interferon treatment

N. Enomoto, M. Kurosaki, I. Sakuma, 2005, Archives of Virology.

Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection.

N. Enomoto, N. Izumi, F. Marumo, 2001, The Journal of infectious diseases.

Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients

N. Enomoto, M. Kurosaki, N. Izumi, 2001, Gut.

Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.

N. Enomoto, M. Kurosaki, N. Izumi, 1999, The Journal of infectious diseases.

Mutations in the interferon‐sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein

N. Enomoto, F. Marumo, C. Sato, 1998, Hepatology.

Mutations in the NS5A region of HCV and interferon efficacy.

N. Enomoto, C. Sato, 1998, Gastroenterology.

Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus‐1b: No association with efficacy of interferon therapy or serum HCV‐RNA levels

N. Enomoto, M. Kurosaki, N. Izumi, 1997, Hepatology.

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis.

N. Enomoto, M. Kurosaki, F. Marumo, 1994, The Journal of general virology.

Detection and quantification of hepatitis C virus RNA replication in the liver.

N. Enomoto, M. Kurosaki, N. Sakamoto, 1994, Journal of hepatology.

Characteristics of hepatitis C viral genome associated with disease progression

N. Enomoto, M. Kurosaki, F. Marumo, 2000, Hepatology.

Nonalcoholic steatohepatitis masquerading as autoimmune hepatitis.

F. Marumo, C. Sato, K. Tajiri, 1997, Journal of clinical gastroenterology.

Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy.

F. Marumo, C. Sato, T. Akiba, 2000, Journal of the American Society of Nephrology : JASN.

Natural history of polypoid lesions in the gall bladder.

F. Marumo, C. Sato, H. Moriguchi, 1996, Gut.

Sequential changes in full-length genomes of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B.

N. Enomoto, M. Kurosaki, N. Izumi, 1996, Journal of hepatology.

An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma.

C. Sato, T. Kamiyama, Y. Tanaka, 1999, Internal medicine.

Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization

N. Enomoto, F. Marumo, C. Sato, 1995, Cancer.

Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues.

N. Enomoto, M. Kurosaki, N. Sakamoto, 1995, Journal of hepatology.

Expression of gap junction protein connexin 32 and E-cadherin in human hepatocellular carcinoma.

F. Marumo, C. Sato, T. Nouchi, 1995, Journal of hepatology.

Host dependent variation of hepatitis C virus: phylogenetic analyses

N. Enomoto, M. Kurosaki, F. Marumo, 2005, Archives of Virology.

Significance of plasma glutathione determination in patients with alcoholic and non‐alcoholic liver disease

F. Marumo, C. Sato, T. Shigesawa, 1992, Journal of gastroenterology and hepatology.

Role of hepatic vitamin A and lipocyte distribution in experimental hepatic fibrosis.

F. Marumo, C. Sato, Y. Tanaka, 2008, Liver.

Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage.

F. Marumo, C. Sato, C. Sato, 1997, The American journal of gastroenterology.

Phenotypic change in portal fibroblasts in biliary fibrosis.

F. Marumo, C. Sato, C. Sato, 2008, Liver.

Characterization of vasopressin-mediated GSH efflux from Hep G2 cells: significance of protein kinase C.

F. Marumo, C. Sato, T. Takano, 1993, Life sciences.

V1-receptor mediated GSH efflux by vasopressin from rat hepatocytes.

N. Izumi, Y. Asahina, F. Marumo, 1992, Life sciences.

CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection

N. Enomoto, N. Sakamoto, N. Izumi, 2001, Journal of medical virology.

Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

N. Enomoto, N. Izumi, F. Marumo, 1996, Digestive diseases and sciences.

Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.

N. Enomoto, F. Marumo, C. Sato, 1996, Journal of hepatology.

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon‐β therapy

N. Enomoto, M. Kurosaki, N. Izumi, 1997, Hepatology.

Long-term observation after transjugular intrahepatic portosystemic stent-shunt in two patients with hepatocellular carcinoma.

C. Sato, J. Tazawa, Y. Miyasaka, 2000, Journal of clinical gastroenterology.

Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis.

F. Marumo, C. Sato, T. Nouchi, 1991, Liver.

Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.

N. Enomoto, M. Kurosaki, Y. Asahina, 1999, The Journal of infectious diseases.

Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis

N. Enomoto, M. Kurosaki, F. Marumo, 2005, Archives of Virology.

Fraction‐specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia

N. Enomoto, M. Kurosaki, I. Sakuma, 1995, Journal of medical virology.

Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver

N. Enomoto, M. Kurosaki, N. Sakamoto, 1995, Journal of medical virology.

Detection of hepatitis C virus RNA in the liver by in situ hybridization.

N. Enomoto, F. Marumo, C. Sato, 2008, Liver.

Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection.

N. Enomoto, M. Kurosaki, N. Sakamoto, 1993, Journal of hepatology.

The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronic hepatitis.

N. Enomoto, M. Kurosaki, N. Sakamoto, 1993, Journal of hepatology.

Primary Budd–Chiari syndrome due to complex venous anomalies

Y. Asahina, F. Marumo, C. Sato, 1997, Abdominal Imaging.

Improvement of peripheral blood lymphocyte subsets in primary biliary cirrhosis after ursodeoxycholic acid therapy

F. Marumo, C. Sato, Takaaki Ikeda, 1996, Journal of gastroenterology and hepatology.

Role of lipid peroxidation in acetaminophen-induced hepatotoxicity: comparison with carbon tetrachloride.

F. Marumo, C. Sato, Jian Liu, 1993, Toxicology letters.

Expression of the hepatocyte growth factor receptor in the regenerating rat liver.

N. Enomoto, M. Kurosaki, N. Sakamoto, 1993, Cancer letters.

Low prevalence of anti‐hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: A multicenter analysis

F. Marumo, C. Sato, T. Akiba, 1996, Journal of medical virology.

Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non‐A, non‐B chronic liver disease

N. Enomoto, M. Kurosaki, N. Sakamoto, 1993, Journal of medical virology.

Expression of gap junction protein connexin 32 in chronic liver diseases.

F. Marumo, C. Sato, T. Nouchi, 2000, Liver.

Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.

N. Izumi, F. Marumo, C. Sato, 1995, Hepatology.

N. Enomoto, M. Kurosaki, N. Izumi, 1999, Virology.

Effects of cadmium on glutathione metabolism in Hep G2 cells.

F. Marumo, C. Sato, T. Takano, 1995, Research communications in molecular pathology and pharmacology.

Adenosine deaminase isoenzymes in liver disease.

F. Marumo, C. Sato, T. Ikeda, 1993, The American journal of gastroenterology.

A variant alkaline phosphatase found in a case of gastric carcinoma with super bone scan.

F. Marumo, C. Sato, T. Komoda, 1995, Gut.

Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.

N. Enomoto, M. Kurosaki, F. Marumo, 1994, Virology.

Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene.

N. Enomoto, M. Kurosaki, F. Marumo, 1994, Journal of hepatology.

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

N. Enomoto, N. Izumi, F. Marumo, 2001, British Journal of Cancer.

Effects of one-year cadmium exposure on livers and kidneys and their relation to glutathione levels.

F. Marumo, C. Sato, T. Akiba, 1995, Research communications in molecular pathology and pharmacology.

Leiomyoma of the common bile duct.

F. Marumo, C. Sato, O. Noguchi, 1993, The American journal of gastroenterology.

Appearance of α‐smooth‐muscle‐actin‐positive cells in hepatic fibrosis

F. Marumo, C. Sato, T. Nouchi, 2008 .

Hemolysis, elevated liver enzymes, and low platelets syndrome associated with primary anti-phospholipid antibody syndrome.

N. Enomoto, N. Izumi, F. Marumo, 1997, Internal medicine.

Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma.

N. Izumi, C. Sato, Takaaki Ikeda, 1993, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

Distribution of hepatitis C virus RNA in the liver and its relation to histopathological changes.

N. Enomoto, F. Marumo, C. Sato, 2008, Liver.

Endoscopic ligation for ruptured duodenal varices.

Y. Asahina, F. Marumo, C. Sato, 1995, The American journal of gastroenterology.

Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.

F. Marumo, C. Sato, Takaaki Ikeda, 1996, Journal of hepatology.

Effect of alcohol drinking on gene expression of hepatic O6-methylguanine DNA methyltransferase in chronic liver diseases.

F. Marumo, C. Sato, Jian Liu, 1996, Alcoholism, clinical and experimental research.

Possible involvement of protein kinase C and calcium in GSH efflux from Hep G2 cells.

N. Izumi, F. Marumo, C. Sato, 1992, Life Science.

Ischemic hepatitis in cirrhosis. clinical features and prognostic implications.

F. Marumo, C. Sato, T. Kamiyama, 1996, Journal of clinical gastroenterology.

Differential gene-expression profiles associated with gastric adenoma

N. Enomoto, M. Kurosaki, N. Sakamoto, 2004, British Journal of Cancer.

Choledochal cyst with adenocarcinoma in the cystically dilated intrahepatic bile duct

F. Marumo, C. Sato, K. Tajiri, 1997, Abdominal Imaging.

Synergistic effect of NADH on NADPH-dependent acetaminophen activation in liver microsomes and its inhibition by cyanide.

F. Marumo, C. Sato, 1991, Life sciences.

Treatment for advanced hepatocellular carcinoma by transarterial chemotherapy using reservoirs or one-shot arterial chemotherapy.

N. Izumi, F. Marumo, C. Sato, 1997, Journal of chemotherapy.

Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.

N. Enomoto, M. Kurosaki, N. Sakamoto, 2004, Journal of viral hepatitis.

Hepatitis C virus quasispecies populations during chronic hepatitis C infection.

N. Enomoto, C. Sato, 1995, Trends in microbiology.

Paracetamol (acetaminophen) bioactivation by liver microsomes — its role in hepatotoxicity

F. Marumo, C. Sato, 1992 .

Inhibition of acetaminophen activation by ethanol and acetaldehyde in liver microsomes.

F. Marumo, C. Sato, T. Nouchi, 1991, Life sciences.

Characterization of the acetaminophen-glutathione conjugation reaction by liver microsomes: species difference in the effects of acetone.

F. Marumo, C. Sato, J. Liu, 1991, Toxicology letters.

Autoimmune hepatitis triggered by administration of an herbal medicine.

C. Sato, T. Nouchi, T. Kamiyama, 1997, The American journal of gastroenterology.

[A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate].

N. Enomoto, N. Izumi, F. Marumo, 1996, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Clinical relevance of hepatitis C virus quasispecies

N. Enomoto, C. Sato, C. Sato, 1995, Journal of viral hepatitis.

Patients with hepatitis A with negative IgM-HA antibody at early stages.

F. Marumo, C. Sato, R. Hirata, 1995, The American journal of gastroenterology.